Bleeding and management of bleeding

Clopidogrel is an effective antiplatelet drug for preventing cardiovascular events and death but also increases the risk of bleeding. There is emerging evidence that bleeding is associated with an increased risk of recurrent ischaemic events and death, even when the bleeding is not severe enough to be considered life-threatening. Reducing the risk of bleeding has the potential to improve clinical outcomes, but it is important to ensure that …